Skip to Content
energy efficientiency
Healthcare

How to make pharma manufacturing more energy efficient

And why it really matters

Download the report3 MB pdf

Global volatility in energy markets looks set to continue for some time. This means organizations in all industries need to make energy efficiency their primary concern. But it is of the utmost importance for energy-intensive sectors with low margins, such as metallurgy, pulp and paper, and fertilizers. In some cases, companies in these sectors have been forced to cease operations. If the pharmaceutical manufacturing, which is considered an energy-intensive space, is going to thrive throughout this period of volatility, it needs to get serious about how it sources, stores, and uses energy. This is because just a 15-20% increase in energy bills would lead to higher medicine prices and disruption to production. So, what’s the next step?

DATA COLLECTION AND MONITORINGENERGY MODELING AND SIMULATIONENERGY MANAGEMENT SYSTEMSPREDICTIVE MAINTENANCEENERGY AUDITING

One of the main levers pharma companies can use is data and digital. The information generated by Capgemini Invent’s technological systems can improve energy performance management. Our holistic approach to energy uses data and digital solutions to target renewable sources, energy reduction plans, and infrastructural improvements. Our new Life Sciences PoV expands on this, highlighting the transformative potential of our technological systems. We can help pharma companies control, optimize, and modify their operational framework for quick wins and long-term growth. Moreover, as a management consultancy, we bring pharma companies up to speed with market movements and outline strategies to harness the advantages of energy efficiency. Our reduce, reuse, and maintain or replace methodology can return the power to pharmaceuticals.

How to Make Pharma Manufacturing More Energy Efficient: And why it really matters

Energy is becoming a key pillar of big pharma’s industrial sustainability strategy. To take this trend in its stride, the industry must embrace the development of renewables and energy efficiency.

Download the report

Contact Our Experts

Broderick Jones

Global Head of Life Science & Med Tech, Capgemini Invent
Broderick brings extensive Life Science and Healthcare experience to each client engagement with the goal of driving top-line growth and building capabilities for ongoing commercial success and cost management. His track record of developing high quality business strategies and transformation plans has driven unparalleled customer experience and internal operational excellence globally.

Malik Belattar

Director, Life Sciences, Capgemini Invent France​
With 20 years of experience, Malik specializes in managing quality, regulatory, and sustainability compliance projects in the pharmaceutical industry. He leads business transformation by developing operational strategies that leverage technological advancements and address emerging needs while ensuring compliance with regulations and GxP requirements. Recently, he has expanded his focus to include trusted AI offerings in Life Sciences, supporting associated project teams

Laurent Saiag

Manager Strategic Research, Capgemini Invent

    Insights

    Point of view

    Will the metaverse be part of the future of healthcare

    capgemini-invent
    Point of view

    Reinventing the unsustainable pharmaceutical R&D model

    capgemini-invent
    Point of view

    Are decentralized clinical trials the future?

    capgemini-invent